Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMST01020023 CE(17:1) cPLA2i 1.0 BCD110605C28 7.15 pmol/sample
LMST01020023 CE(17:1) cPLA2i 1.0 BCD110605C30 3.44 pmol/sample
LMST01020023 CE(17:1) cPLA2i 1.0 BCD110605C29 2.35 pmol/sample
LMST01020023 CE(17:1) cPLA2i 20.0 BCD110605C64 6.19 pmol/sample
LMST01020023 CE(17:1) cPLA2i 20.0 BCD110605C66 3.44 pmol/sample
LMST01020023 CE(17:1) cPLA2i 20.0 BCD110605C65 3.23 pmol/sample
LMST01020023 CE(17:1) PLDi 1.0 BCD110605C16 7.22 pmol/sample
LMST01020023 CE(17:1) PLDi 1.0 BCD110605C17 2.98 pmol/sample
LMST01020023 CE(17:1) PLDi 1.0 BCD110605C18 1.85 pmol/sample
LMST01020023 CE(17:1) PLDi 20.0 BCD110605C54 2.61 pmol/sample
LMST01020023 CE(17:1) PLDi 20.0 BCD110605C52 4.8 pmol/sample
LMST01020023 CE(17:1) PLDi 20.0 BCD110605C53 2.94 pmol/sample
LMST01020023 CE(17:1) KDO+cPLA2i 1.0 BCD110605C32 1.57 pmol/sample
LMST01020023 CE(17:1) KDO+cPLA2i 1.0 BCD110605C31 4.74 pmol/sample
LMST01020023 CE(17:1) KDO+cPLA2i 1.0 BCD110605C33 2.34 pmol/sample
LMST01020023 CE(17:1) KDO+cPLA2i 20.0 BCD110605C68 2.91 pmol/sample
LMST01020023 CE(17:1) KDO+cPLA2i 20.0 BCD110605C69 4.65 pmol/sample
LMST01020023 CE(17:1) KDO+cPLA2i 20.0 BCD110605C67 5.52 pmol/sample
LMST01020023 CE(17:1) KDO+PLDi 1.0 BCD110605C19 4.02 pmol/sample
LMST01020023 CE(17:1) KDO+PLDi 1.0 BCD110605C20 2.12 pmol/sample
LMST01020023 CE(17:1) KDO+PLDi 1.0 BCD110605C21 2.7 pmol/sample
LMST01020023 CE(17:1) KDO+PLDi 20.0 BCD110605C56 2.45 pmol/sample
LMST01020023 CE(17:1) KDO+PLDi 20.0 BCD110605C57 2.72 pmol/sample
LMST01020023 CE(17:1) KDO+PLDi 20.0 BCD110605C55 6.29 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+cPLA2i 1.0 BCD110605C37 4.52 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+cPLA2i 1.0 BCD110605C38 3.06 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+cPLA2i 1.0 BCD110605C39 2.94 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+cPLA2i 20.0 BCD110605C74 2.54 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+cPLA2i 20.0 BCD110605C75 3.91 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+cPLA2i 20.0 BCD110605C73 6.02 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+PLDi 1.0 BCD110605C25 5.14 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+PLDi 1.0 BCD110605C27 2.72 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+PLDi 1.0 BCD110605C26 1.73 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+PLDi 20.0 BCD110605C61 4.92 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+PLDi 20.0 BCD110605C62 2.4 pmol/sample
LMST01020023 CE(17:1) KDO+ATP+PLDi 20.0 BCD110605C63 4.15 pmol/sample
LMST01020023 CE(17:1) KDO + ATP 1.0 BCD110605C15 2.12 pmol/sample
LMST01020023 CE(17:1) KDO + ATP 1.0 BCD110605C14 2.81 pmol/sample
LMST01020023 CE(17:1) KDO + ATP 1.0 BCD110605C13 5 pmol/sample
LMST01020023 CE(17:1) KDO + ATP 20.0 BCD110605C49 4.18 pmol/sample
LMST01020023 CE(17:1) KDO + ATP 20.0 BCD110605C50 2.11 pmol/sample
LMST01020023 CE(17:1) KDO + ATP 20.0 BCD110605C51 2.79 pmol/sample
LMST01020023 CE(17:1) KDO 1.0 BCD110605C08 1.95 pmol/sample
LMST01020023 CE(17:1) KDO 1.0 BCD110605C07 4.19 pmol/sample
LMST01020023 CE(17:1) KDO 1.0 BCD110605C09 1.54 pmol/sample
LMST01020023 CE(17:1) KDO 20.0 BCD110605C45 3.98 pmol/sample
LMST01020023 CE(17:1) KDO 20.0 BCD110605C44 1.98 pmol/sample
LMST01020023 CE(17:1) KDO 20.0 BCD110605C43 5.38 pmol/sample
LMST01020023 CE(17:1) C 0.0 BCD110605C03 9.73 pmol/sample
LMST01020023 CE(17:1) C 0.0 BCD110605C01 13.9 pmol/sample